DRUG  REGULATION  IN  iNDIA

 

India has the depressing record of having at least 5 major DEG (diethyline glucol) 

poisoning events. When several children were severely ill in two hospitals in 2019, it

was found that a cough syrup they consumed tested positive of diethyline glycol, which

is a powerful industial solvent that is used in the manufacture of antifreeze, brake fluid etc.

Indian pharmaceutical companies quite often fail to test either the raw materials or the final

formulation before shipping to the market. 


               Many cases under investigation remain pending for a long time. Punishments are 

often very small, due to lenient judges. Many times manufactured drugs fail quality testing.

India had its first ever Drug Act in 1940.  Indian pharmaceutical industry has grown 

exponentially during the twentieth century. Still, India's regulatory infrastructure has 

evolved at a snail's pace. Only a few states liike Tamil Nadu and Gujarat appear to have 

well-equipped drug-testing laboratories. Six central and regional laboratories were 

equipped with good testing facilities.


               Another revealing fact is that Indian doctors are aware that many formulations of 

generic medicines manufactured in India do not have the expected therapeutic effect on 

their patients. Pharmaceutical companies are also known to have improper influence on 

drug regulation in India.


                                 ( Based on the book "The Truth Pill", written by

                                         Dinesh Thakur and Prashant Reddy)  



Comments

Popular posts from this blog